Patent Details
The company's US patent application entitled "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER" has been granted. The patent protects a novel class of compounds that effectively inhibit cancer and cancer stem cells. The invention shows significant potential against various cancer types, specifically including breast and prostate cancer.
Documentation
The grant certificate was attached to the disclosure submission for reference.